PMC:7696151 / 39442-39692 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1151","span":{"begin":45,"end":48},"obj":"Chemical"},{"id":"1152","span":{"begin":190,"end":193},"obj":"Chemical"},{"id":"1160","span":{"begin":154,"end":174},"obj":"Disease"}],"attributes":[{"id":"A1151","pred":"tao:has_database_id","subj":"1151","obj":"MESH:D006886"},{"id":"A1152","pred":"tao:has_database_id","subj":"1152","obj":"MESH:D006886"},{"id":"A1160","pred":"tao:has_database_id","subj":"1160","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"eve the blood concentration required for the HCQ antiviral activity. Initially, based on physiological pharmacokinetic models, Yao et al. recommended for SARS-CoV-2 infection a loading oral HCQ dose of 400 mg twice daily, followed by a maintenance do"}